Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2019 1
2020 281
Text availability
Article attribute
Article type
Publication date

Search Results

282 results
Results by year
Filters applied: . Clear all
Page 1
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents.
Bishara D, Kalafatis C, Taylor D. Bishara D, et al. Ther Adv Psychopharmacol. 2020 Jun 22;10:2045125320935306. doi: 10.1177/2045125320935306. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 32612804 Free PMC article. Review.
As yet, no agents have been approved for the treatment of COVID-19, although several experimental drugs are being used off licence. ...A preliminary search identified the following drugs as being used to treat COVID-19 symptoms: atazanavir (ATV), azith …
As yet, no agents have been approved for the treatment of COVID-19, although several experimental drugs are being used off lic …
Lessons Learned so Far from the Pandemic: A Review on Pregnants and Neonates with COVID-19.
Marim F, Karadogan D, Eyuboglu TS, Emiralioglu N, Gurkan CG, Toreyin ZN, Akyil FT, Yuksel A, Arikan H, Serifoglu I, Gursoy TR, Sandal A, Akgun M. Marim F, et al. Eurasian J Med. 2020 Jun;52(2):202-210. doi: 10.5152/eurasianjmed.2020.20118. Eurasian J Med. 2020. PMID: 32612432 Free PMC article. Review.
There are concerns regarding the risk and the course of COVID-19 in pregnancy and in the neonates. In this review, we aimed to present the current understanding of severe acute respiratory syndrome coronavirus 2 (SARS
There are concerns regarding the risk and the course of COVID-19 in pregnancy and in the neonates. In this review, we aimed to …
Clinical management of COVID-19.
Varghese GM, John R, Manesh A, Karthik R, Abraham OC. Varghese GM, et al. Indian J Med Res. 2020 May;151(5):401-410. doi: 10.4103/ijmr.IJMR_957_20. Indian J Med Res. 2020. PMID: 32611911 Review.
The novel coronavirus disease 2019 (COVID-19) with its early origin from Wuhan city in China has evolved into a global pandemic. ...While many drugs have shown in vitro activity against severe acute respiratory syndrome
The novel coronavirus disease 2019 (COVID-19) with its early origin from Wuhan city in China has evolved …
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19.
Tempestilli M, Caputi P, Avataneo V, Notari S, Forini O, Scorzolini L, Marchioni L, Ascoli Bartoli T, Castilletti C, Lalle E, Capobianchi MR, Nicastri E, D'Avolio A, Ippolito G, Agrati C. Tempestilli M, et al. J Antimicrob Chemother. 2020 Jul 1:dkaa239. doi: 10.1093/jac/dkaa239. Online ahead of print. J Antimicrob Chemother. 2020. PMID: 32607555
BACKGROUND: Remdesivir is a prodrug of the nucleoside analogue GS-441524 and is under evaluation for treatment of SARS-CoV-2-infected patients. OBJECTIVES: To evaluate the pharmacokinetics of remdesivir and GS-441524 in plasma, bronchoalveolar a …
BACKGROUND: Remdesivir is a prodrug of the nucleoside analogue GS-441524 and is under evaluation for treatment of SARS-CoV
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
Xie X, Muruato AE, Zhang X, Lokugamage KG, Fontes-Garfias CR, Zou J, Liu J, Ren P, Balakrishnan M, Cihlar T, Tseng CK, Makino S, Menachery VD, Bilello JP, Shi PY. Xie X, et al. bioRxiv. 2020 Jun 23:2020.06.22.165712. doi: 10.1101/2020.06.22.165712. Preprint. bioRxiv. 2020. PMID: 32607511 Free PMC article.
A high-throughput platform would greatly facilitate COVID-19 serological testing and antiviral screening. Here we report a nanoluciferase SARS-CoV-2 (SARS-CoV-2-Nluc) that is genetically stable and replicates similarly to th …
A high-throughput platform would greatly facilitate COVID-19 serological testing and antiviral screening. Here we report a nan …
Coronavirus (COVID-19) Fulminant Myopericarditis and Acute Respiratory Distress Syndrome (ARDS) in a Middle-Aged Male Patient.
Hussain H, Fadel A, Alwaeli H, Guardiola V. Hussain H, et al. Cureus. 2020 Jun 24;12(6):e8808. doi: 10.7759/cureus.8808. Cureus. 2020. PMID: 32607304 Free PMC article.
Despite the current comprehensive knowledge of myocardial injury in viral and post-viral myopericarditis, the cellular and molecular mechanisms of SARS-CoV-2-induced myopericarditis are poorly understood. This report presents a case of coronavirus ( …
Despite the current comprehensive knowledge of myocardial injury in viral and post-viral myopericarditis, the cellular and molecular mechani …
Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1.
Tarasova O, Ivanov S, Filimonov DA, Poroikov V. Tarasova O, et al. Molecules. 2020 Jun 26;25(12):E2944. doi: 10.3390/molecules25122944. Molecules. 2020. PMID: 32604797
An example is a variant of coronaviruses (CoV) causing severe acute respiratory syndrome (SARS), named SARS-CoV-2. Some antiviral drugs, such as remdesivir as well as antiretroviral drugs including darunavir, l …
An example is a variant of coronaviruses (CoV) causing severe acute respiratory syndrome (SARS), n …
A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era.
Lee J, Shin HW, Lee JY, Kim JS, Yang JW, Lee KH, Kronbichler A, Shin JI. Lee J, et al. Medicina (Kaunas). 2020 Jun 26;56(6):E315. doi: 10.3390/medicina56060315. Medicina (Kaunas). 2020. PMID: 32604775
Background and objective: Despite medical advances, we are facing the unprecedented disaster of the coronavirus disease 2019 (COVID-19) pandemic without available treatments and effective vaccines. ...Thus, this study aims at providing a comprehensive …
Background and objective: Despite medical advances, we are facing the unprecedented disaster of the coronavirus disease 2019 ( …
Current pharmacological treatments for SARS-COV-2: A narrative review.
Nittari G, Pallotta G, Amenta F, Tayebati SK. Nittari G, et al. Eur J Pharmacol. 2020 Jun 27;882:173328. doi: 10.1016/j.ejphar.2020.173328. Online ahead of print. Eur J Pharmacol. 2020. PMID: 32603692 Free PMC article. Review.
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 2019, quickly spread around the world becoming a pandemic. ...Several in vitro and in vivo studies were rapidly initiated after the outbrea …
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in November 201
282 results
Jump to page
Feedback